Catalyst
Slingshot members are tracking this event:
Vanda Patents Found Valid and Infringed in Fanapt ANDA Litigation
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNDA |
|
|
||||
Additional Information
"We are very pleased that the court found both patents valid, found that Roxane's ANDA infringes the '198 patent and the '610 patent, and accordingly issued an injunction barring Roxane from marketing its product until the expiration of the later expiring '610 patent on November 2, 2027," said Mihael H. Polymeropoulos, M.D., Vanda's President and CEO.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 25, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fanapt, Anda Patent Litigation, Roxane
